After the talk of Ozempic face and hair loss, a Portuguese-language post points to a digestive symptom it says may signal something more in GLP-1 patients.
Recap by typeshit. Post by Facebook on Facebook.
Dr Bajekal flags that people on Mounjaro, semaglutide or Wegovy should talk it through with their doctor ahead of an operation.
The Form 483 cites microbial growth in a clean hood, reversed cleanroom air pressure and active ingredients marked for research use only. Check which pharmacy filled your vial.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
A short explainer on why these drugs are surging in popularity and what questions remain about their wider effects.
He points out Lilly isn't planning to file with the FDA until early 2027, so anything sold online now is unapproved. A caution worth reading before buying.
Loading…